Skip To Content

Thought leadership on the clinical impact on workers' compensation and auto no-fault.

Recent blog posts

April 20, 2020 · Clinical Connection team
Epidiolex oral solution ‒ the only cannabidiol (CBD) prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat epilepsy ‒ is no longer considered a controlled substance under the federal Controlled Substances Act. Read more...
April 06, 2020 · Clinical Connection team
The Food and Drug Administration (FDA) announced on April 1, 2020 it will be requesting manufacturers remove all prescription and over-the-counter (OTC) ranitidine products, a popular histamine (H2)-blocker, from the market immediately. Ranitidine recalls initially began last fall Read more...
April 02, 2020 · From the desk of David W. Young
While there are many unknowns, Optum Workers’ Compensation and Auto No-Fault is committed to our customers, claimants and our team members. We remain fully staffed and operational and continue to ensure that the injured person is receiving the right treatment at the right time for the right duration and for the most appropriate cost. Read more...
March 23, 2020
The combination of two non-opioid analgesic medications used to treat pain and inflammation will soon be available over-the-counter (OTC), according to the U.S. Food and Drug Administration (FDA) and an announcement from GlaxoSmithKline (GSK) on March 2, 2020. Read more...
March 18, 2020 · From the desk of David W. Young
Given the recent developments and extensive news coverage about COVID-19, we understand the heightened concerns of our clients, partners and injured persons. At Optum Workers’ Comp and Auto No-Fault, our top priorities are the health and wellbeing of those we serve and the safety of those who deliver care; and we stand ready to support your needs during these challenging times.  Our dedicated employees have rigorously planned and tested our processes, systems and supply chains for business continuity, resiliency and recovery to do everything possible to support the health of those we are privileged to serve. Read more...
March 04, 2020 · Clinical Connection team
The novel coronavirus (COVID-19), that began to emerge in late 2019, has become an increasing public health concern due to its ease of person-to-person transmission. Read more...
February 27, 2020 · Clinical Connection team
Voltaren Gel 1% (diclofenac sodium topical gel) ― a common medication in workers’ compensation and auto no-fault ― will soon transition from prescription (Rx) to over-the-counter (OTC) status, according to the U.S. Food and Drug Administration (FDA). Read more...
<< Previous      Next >>
Page 2 of 5

Subscribe today to receive our latest blogs, articles and more.

Subscribe now button

Download the latest
Pharmacy Resource Guide

Pharmacy Resource Guide